Figure 3From: High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinomaOverall survival from the time of the first stereotactic body radiotherapy (SBRT) treatment. (a) All patients (n = 82); (b) By SBRT dose; (c) By Barcelona Clinic Liver Cancer (BCLC) stage. yr, year.Back to article page